GENEO Capital Entrepreneur
GENEO Capital Entrepreneur is a French private equity firm founded in 2019, managing an evergreen fund with €740 million under management, dedicated to supporting the long-term growth and transfer of SMEs and ETIs through tailor-made capital and operational support.
Key facts
Recent exits
Coverage notes
2 funds tracked, 31 portfolio companies (29 active · 2 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund GENEO Capital Entrepreneur has raised, with its portfolio companies. Hand-checked from public filings.
GENEO MezzaninePrivate Debt2022 · 4yr€140M5 active
Unrealized
5 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| DAP | – | – | 2025 |
| ENYGEA | Business Services | France | 2022 |
| MLab | – | – | 2025 |
| My Variations | – | – | – |
| Pastacorp | – | – | – |
GENEO CapitalGrowth2019 · 7yr€600M24 active · 2 realized
Unrealized
24 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| ACS | Financials | France | 2024 |
| BBL GROUP | Industrials | France | 2020 |
| ChapsVision | Software | France | 2023 |
| Coverpla | Industrials | France | 2024 |
| Didactic | Healthcare | France | 2024 |
| DSL | Business Services | France | 2021 |
| ENYGEA | Business Services | France | 2022 |
| G.A.C GROUP | Business Services | France | 2022 |
| GBNA Polycliniques | Healthcare | France | 2021 |
| HOPPEN | Healthcare | France | 2019 |
| Kardham | Business Services | France | 2020 |
| Kinougarde Complétude | Business Services | France | 2021 |
| Leader Group | Industrials | France | 2021 |
| Magiline | Industrials | France | 2021 |
| NEFTYS-PHARMA | Healthcare | France | 2022 |
| Odigo | TMT | France | 2022 |
| OTEGO | Industrials | France | 2020 |
| Pinette PEI | Industrials | France | 2019 |
| Seiven | Consumer | France | 2025 |
| Sterimed | MedTech | France | 2025 |
| Valtus | Business Services | France | 2020 |
| Wirun | Consumer | France | 2022 |
| XEFI | TMT | France | 2022 |
| Zurflüh-Feller | Industrials | France | 2022 |
Realized
2 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Convictions RH | Business Services | France | 2020 | 2025 | Trade Sale | – | |
| Human and Work | Business Services | France | 2019 | 2024 | Trade Sale | – |
Saved GPs appear in your watchlist, one click from your workspace.
About GENEO Capital Entrepreneur
GENEO Capital Entrepreneur is a French private equity firm with €740 million of assets under management as of December 2024, founded in 2019 and headquartered in Paris. The firm manages an evergreen fund dedicated to supporting the long-term growth and transfer of French SMEs, distinguishing the platform with the evergreen permanent capital structure aligned with patient capital and management transition scenarios.
Investment thesis
GENEO targets French SMEs and mid-cap companies seeking patient capital for growth, succession or management buyout scenarios, with the evergreen fund structure enabling long-duration positions unconstrained by traditional fund cycles. Sector focus spans Business Services, Industrials and Healthcare, with the platform emphasising operational partnership and patient capital deployment alongside owner-operator management teams.
Recent activity
Recent realised exits include Convictions RH (business services, 2025), Human and Work (business services, 2024) and Zurflüh-Feller (industrials, 2022), reflecting selective distribution across the evergreen portfolio. The platform tracks 2 funds and 26 active portfolio companies across the long-duration French SME programme. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
France·€196.0BFrance·€52.8BFrance·€40.8BFrance·€33.0BFrance·€27.0BFrance·€13.2BFrance·€11.6BFrance·€9.0BFrance·€7.0BFrance·€6.7BFrance·€6.0BFrance·€5.1B